213 related articles for article (PubMed ID: 18655474)
1. [The role of major vessels remodeling in development of left ventricular hypertrophy in patients with a predialysis stage of chronic renal failure].
Kutyrina IM; Rudenko TE; Shvetsov MIu; Kushnir VV
Ter Arkh; 2008; 80(6):37-41. PubMed ID: 18655474
[TBL] [Abstract][Full Text] [Related]
2. [Risk factors and pathogenetic mechanisms of left ventricular hypertrophy in progressive chronic kidney disease and after transplantation of the kidney].
Tomilina NA; Storozhakov GI; Gendlin GE; Badaeva SV; Zhidkova DA; Kim IG; Borisovskaia SV; Loss KE; Fedorova ND
Ter Arkh; 2007; 79(6):34-40. PubMed ID: 17684964
[TBL] [Abstract][Full Text] [Related]
3. [Factors influencing the condition of the intima-media complex of carotid and femoral arteries at initial stages of chronic renal failure].
Rudenko TE; Kutyrina IM; Kushnir VV; Shvetsov MIu
Ter Arkh; 2005; 77(6):46-50. PubMed ID: 16078600
[TBL] [Abstract][Full Text] [Related]
4. [Heart remodeling in patients with predialysis phase of chronic renal failure].
Shutov AM; Kondrat'eva NI; Kulikova ES; Ivashkina TN; Tomnikovskaia VS; Shepeleva GI
Ter Arkh; 2000; 72(6):46-9. PubMed ID: 10900649
[TBL] [Abstract][Full Text] [Related]
5. [Risk factors for myocardial remodeling at stage II-IV of chronic kidney disease].
Rudenko TE; Kutyrina IM; Shvetsov MIu
Ter Arkh; 2012; 84(6):21-6. PubMed ID: 22997913
[TBL] [Abstract][Full Text] [Related]
6. [Diastolic dysfunction in different types of left ventricular hypertrophy in patients with end-stage renal failure: impact of long-term erythropoietin therapy].
Dzgoeva FU; Gatagonova TM; Kadzaeva ZK; Khamitsaeva OV; Kochisova ZKh; Dzueva AT; Bazaeva BG; Bestaeva TL
Ter Arkh; 2013; 85(6):44-50. PubMed ID: 23866598
[TBL] [Abstract][Full Text] [Related]
7. Determinants of left ventricular hypertrophy and systolic dysfunction in chronic renal failure.
Greaves SC; Gamble GD; Collins JF; Whalley GA; Sharpe DN
Am J Kidney Dis; 1994 Nov; 24(5):768-76. PubMed ID: 7977318
[TBL] [Abstract][Full Text] [Related]
8. [Risk factors of vascular complications in patients at a predialysis stage of chronic renal failure].
Kutyrina IM; Rudenko TE; Shvetsov MIu; Kushnir VV
Ter Arkh; 2006; 78(5):45-50. PubMed ID: 16889049
[TBL] [Abstract][Full Text] [Related]
9. [Effects of arterial compliance on geometry of the left ventricle in patients with pre-dialysis chronic renal failure].
Shutov AM; Kulikova ES; Kondrat'eva NI; Ivashkina TN
Klin Med (Mosk); 2001; 79(11):36-9. PubMed ID: 11811106
[TBL] [Abstract][Full Text] [Related]
10. Correlation between hypervolemia, left ventricular hypertrophy and fibroblast growth factor 23 in hemodialysis patients.
Unver S; Kavlak E; Gümüsel HK; Celikbilek F; Esertas K; Muftuoglu T; Kirilmaz A
Ren Fail; 2015 Jul; 37(6):951-6. PubMed ID: 26030798
[TBL] [Abstract][Full Text] [Related]
11. Obesity promotes left ventricular concentric rather than eccentric geometric remodeling and hypertrophy independent of blood pressure.
Woodiwiss AJ; Libhaber CD; Majane OH; Libhaber E; Maseko M; Norton GR
Am J Hypertens; 2008 Oct; 21(10):1144-51. PubMed ID: 18756261
[TBL] [Abstract][Full Text] [Related]
12. Patterns of left ventricular hypertrophy in chronic kidney disease: an echocardiographic evaluation.
Sambi RS; Gaur AK; Hotchandani R; Aggarwal KK; Kaur S; Gupta M; Jain S; Krishna CK; Chopra HK; Anand V; Srivastava S; Gupta R; Parashar SK
Indian Heart J; 2011; 63(3):259-68. PubMed ID: 22734347
[TBL] [Abstract][Full Text] [Related]
13. [Calcification of peripheral arteries in patients with terminal renal failure on programmed hemodialysis].
Dzitoeva MIu; Milovanov IuS; Shilov EM; Safonov VV; Milovanova LIu; Kushnir VV
Ter Arkh; 2005; 77(6):50-4. PubMed ID: 16078601
[TBL] [Abstract][Full Text] [Related]
14. Left ventricular remodeling and arterial remodeling in patients with chronic kidney disease stage 1-3.
Pluta A; Stróżecki P; Krintus M; Odrowąż-Sypniewska G; Manitius J
Ren Fail; 2015 Aug; 37(7):1105-10. PubMed ID: 26156686
[TBL] [Abstract][Full Text] [Related]
15. The effects of maintenance recombinant human erythropoietin therapy on ambulatory blood pressure recordings: conventional, Doppler, and tissue Doppler echocardiographic parameters.
Kirkpantur A; Kahraman S; Yilmaz R; Arici M; Altun B; Erdem Y; Yasavul U; Turgan C
Artif Organs; 2005 Dec; 29(12):965-72. PubMed ID: 16305652
[TBL] [Abstract][Full Text] [Related]
16. Left ventricular and carotid structure in untreated, uncomplicated essential hypertension: results from the Assessment Prognostic Risk Observational Survey (APROS).
Cuspidi C; Mancia G; Ambrosioni E; Pessina A; Trimarco B; Zanchetti A;
J Hum Hypertens; 2004 Dec; 18(12):891-6. PubMed ID: 15284833
[TBL] [Abstract][Full Text] [Related]
17. Prevalence and patterns of left ventricular hypertrophy in patients with predialysis chronic renal failure.
Ha SK; Park HS; Kim SJ; Park CH; Kim DS; Kim HS
J Korean Med Sci; 1998 Oct; 13(5):488-94. PubMed ID: 9811177
[TBL] [Abstract][Full Text] [Related]
18. Cardiac and arterial interactions in end-stage renal disease.
London GM; Guerin AP; Marchais SJ; Pannier B; Safar ME; Day M; Metivier F
Kidney Int; 1996 Aug; 50(2):600-8. PubMed ID: 8840292
[TBL] [Abstract][Full Text] [Related]
19. Left ventricular hypertrophy in nondiabetic predialysis CKD.
Paoletti E; Bellino D; Cassottana P; Rolla D; Cannella G
Am J Kidney Dis; 2005 Aug; 46(2):320-7. PubMed ID: 16112052
[TBL] [Abstract][Full Text] [Related]
20. Gender differences in mediators of left ventricular hypertrophy in dialysis patients.
Savage T; Giles M; Tomson CV; Raine AE
Clin Nephrol; 1998 Feb; 49(2):107-12. PubMed ID: 9524781
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
